raynovich

Biotech Breakdown: Seeking Relief Today

At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218
—-
Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349
Biotech Breakdown: Relief Today Or Another Head Fake?
Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. There is bit of buying today and most biotechnology […]

Biotech Stocks Shake Off Fears of Greek Crisis

About Raynovich Rod
Rod Raynovich is an experienced biotech investor and analyst with a focus in vaccines, tools, IVD’s and biopharmaceuticals. Prior to starting Raygent.com, he was a former technology transfer office at UCLA and he has held various executive positions in the biotech and medical device industry, including senior positions at NASDAQ listed biomedical companies. Prior to that Mr.Raynovich held […]

Biotech Stocks Lose Momentum with Greece Crisis; Blockbuster Immunotherapy Deal

Biotech Stocks in Broad Sell-Off
The biotech sector is usually immune to macro events but today the crisis in Greece gave investors an excuse to take profits. Many biotech stocks and ETFs were down over 3% faring worse than the NASDAQ down 2.4%. The sector, as tracked by IBB, is still up 18.87% YTD after hitting a high of 383 on […]

Biotech ETF Trending Shows Shift To Speculative Stocks: XBI

Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]

Biotech Bull Market: Trends to Watch in 2015… #3

Biotech Sector Moves Up In Tiny Steps
Risk Remains On
AACR Next Week Will Move Cancer Stocks
Biotech indices and ETFs are trying to hit new highs but momentum is easing and trading is choppy. Nonetheless we are moving up from the brief correction near channel lows at the end of Q1. Sentiment remains strong.
Here is a review of the Five Trends we […]

Biotech Stocks Are Apparently Immune to Risks of the Day: New Highs Again …Update

Update 1/27 After the Close Amgen Beats
Amgen, Inc (AMGN) fourth quarter earnings and sales beat estimates on strong sales of Enbrel, an arthritis drug.Revenue for Q4 was $5,33B a 6% increase over Q4 2013, The stock was up slightly after hours to $159.40. Sales growth was also driven by Kyprolis and Prolia. The P/S is still a modest 6.12 and […]

Energy Weakness Rolls Over To Biotech Stocks

Biotech Stocks Sell-Off After Hitting New Highs Monday
NASDAQ at 4735 off 0.67%
Healthcare and life science stocks have been a safe haven from recent market headwinds but today risk is off across the board. Crude is down over 5% to $61 and this has raised concerns about global growth affecting other asset classes like financials and industrials.The Dow and S&P are […]

Rayno Life Science: Market Update 11/26… Stocks Cruise To New Highs

NASDAQ leads -up 0.6% to 4787
The October correction of ~7% was a “headfake” as macro events scared many investor away
Technology and Healthcare Stocks Lead The Way
The healthcare SPDR (XLV) is up 24.5% YTD and the technology SPDR (XLK) is up 18% YTD.
Biotech stocks are at new highs with all major ETFs rallying in November. Our top ETF pick FBT is […]